We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current WVE market cap is 725.14M. The company's latest EPS is USD -1.3233 and P/E is -4.47.
| Quarter End | Jun 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 375k | 949k | 13.94M | 22.22M | 49.39M |
| Operating Income | -41.42M | -43.85M | -29.28M | -23.36M | 4.62M |
| Net Income | -41.3M | -43.71M | -27.41M | -21.1M | 7.25M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.41M | 15.98M | 20.08M | 40.96M | 3.66M |
| Operating Income | -149.97M | -198.58M | -151.32M | -122.48M | -162.71M |
| Net Income | -146.65M | -193.64M | -149.91M | -122.25M | -161.82M |
| Quarter End | Jun 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 213.32M | 146.39M | 267.27M | 229.99M | 199.92M |
| Total Liabilities | 174.5M | 191.48M | 301.98M | 273.83M | 240.4M |
| Total Equity | 38.82M | -45.09M | -34.71M | -43.85M | -40.49M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 295.94M | 284.25M | 279.24M | 207.01M | 146.39M |
| Total Liabilities | 222.59M | 212.64M | 188.59M | 174.51M | 191.48M |
| Total Equity | 73.35M | 71.61M | 90.65M | 32.5M | -45.09M |
| Quarter End | Jun 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -68.7M | -127.78M | 85.52M | 48.27M | 13.81M |
| Investing | -25.59M | -1.26M | -489k | -561k | -759k |
| Financing | 67.12M | 67.19M | 35.05M | 36.9M | 38.57M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.86M | -188.23M | -115.98M | -88.99M | -127.78M |
| Investing | -9.94M | -3.92M | -1.34M | -560k | -1.26M |
| Financing | 65.09M | 164.4M | 154.54M | 55.83M | 67.19M |
| Market Cap | 725.14M |
| Price to Earnings Ratio | -4.47 |
| Price to Sales Ratio | 197.99 |
| Price to Cash Ratio | 8.18 |
| Price to Book Ratio | -16.05 |
| Dividend Yield | - |
| Shares Outstanding | 122.28M |
| Average Volume (1 week) | 834.49k |
| Average Volume (1 Month) | 593.42k |
| 52 Week Change | 46.42% |
| 52 Week High | 7.67 |
| 52 Week Low | 2.50 |
| Spread (Intraday) | 0.02 (0.34%) |
| Company Name | Wave Life Sciences Ltd |
| Address |
8 cross street #10-00����� singapore 018936 |
| Website | https://www.wavelifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
